RUNX1 and acute myeloid leukemia: Successful AML (FA-AML1 or Kasumi-1) engraftment in NSG mice was confirmed by positive HLA-DR expression (compared to unstained controls) in peripheral blood by flow cytometry 8–14 weeks post leukemic cell injection (Fig 1A and 1B).